These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11769096)

  • 21. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial drug discovery in the 21st century.
    Bush K
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():10-7. PubMed ID: 15522035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New trends in studies of the pharmacologic activity of microbial metabolites].
    Chmiel A
    Postepy Hig Med Dosw; 1989; 43(1):119-60. PubMed ID: 2697872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbial natural products: alive and well in 1998.
    Demain AL
    Nat Biotechnol; 1998 Jan; 16(1):3-4. PubMed ID: 9447575
    [No Abstract]   [Full Text] [Related]  

  • 25. An aminoglycoside microarray platform for directly monitoring and studying antibiotic resistance.
    Disney MD; Barrett OJ
    Biochemistry; 2007 Oct; 46(40):11223-30. PubMed ID: 17867707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of glycodiversification: expedient synthesis and antibacterial evaluation of a library of kanamycin B analogues.
    Li J; Wang J; Czyryca PG; Chang H; Orsak TW; Evanson R; Chang CW
    Org Lett; 2004 Apr; 6(9):1381-4. PubMed ID: 15101747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuning the regioselectivity of the Staudinger reaction for the facile synthesis of kanamycin and neomycin class antibiotics with N-1 modification.
    Li J; Chen HN; Chang H; Wang J; Chang CW
    Org Lett; 2005 Jul; 7(14):3061-4. PubMed ID: 15987205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy.
    Jayasuriya H; Zink D; Basilio A; Vicente F; Collado J; Bills G; Goldman ML; Motyl M; Huber J; Dezeny G; Byrne K; Singh SB
    J Antibiot (Tokyo); 2009 May; 62(5):265-9. PubMed ID: 19343064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The fight against bacteria: the antibiotics policy].
    Sztaricskai F
    Acta Pharm Hung; 2001; 71(1):89-98. PubMed ID: 11769102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance and microbial composition along the manufacturing process of Mozzarella di Bufala Campana.
    Devirgiliis C; Caravelli A; Coppola D; Barile S; Perozzi G
    Int J Food Microbiol; 2008 Dec; 128(2):378-84. PubMed ID: 18990462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular system research at the Institute of Drug Research].
    Mátyus P
    Acta Pharm Hung; 2001; 71(1):67-72. PubMed ID: 11769098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical antibacterial drug discovery--foundation in natural products.
    Singh SB; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):1006-15. PubMed ID: 16412984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Looking into the future.
    Potts M
    Plan Parent Rev; 1983; 3(2):3-5. PubMed ID: 12265636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics.
    Kim S; Lee SW; Choi EC; Choi SY
    Appl Microbiol Biotechnol; 2003 May; 61(4):278-88. PubMed ID: 12743756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can biotech deliver new antibiotics?
    Barrett JF
    Curr Opin Microbiol; 2005 Oct; 8(5):498-503. PubMed ID: 16125445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel strategies for the synthesis of anthrapyran antibiotics: discovery of a new antitumor agent and total synthesis of (S)-espicufolin.
    Tietze LF; Gericke KM; Singidi RR; Schuberth I
    Org Biomol Chem; 2007 Apr; 5(8):1191-200. PubMed ID: 17406717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient total synthesis of novel bioactive microbial metabolites.
    Sunazuka T; Hirose T; Omura S
    Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tobramycin impurities for quality control process monitoring using high-performance anion-exchange chromatography with integrated pulsed amperometric detection.
    Hanko VP; Rohrer JS; Liu HH; Zheng C; Zhang S; Liu X; Tang X
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):828-33. PubMed ID: 18486398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.